GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Skinvisible SKVI · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.18

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Skinvisible

From its filings with the US Securities and Exchange Commission

SEC filings

Skinvisible is based in Las Vegas, Nevada and is incorporated in Nevada. Its shares trade on OTC under the ticker SKVI. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $20,000 and a net loss of $1.1m. At that date it held total assets of $127,567 and shareholders' equity of −$10.3m.

Read the filing on SEC.gov ↗

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
7 Jan 1999
Employees
2
Head office
6320 S SANDHILL ROAD, LAS VEGAS, NV, 89120
Incorporated in
NV
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Terry HowlettChief Executive Officer, Chief Financial Officer, Director, since 1998$180,000
  • Ms. Doreen McmorranVice President - Business Development
  • Mr. David St. JamesIndependent Director$6,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Skinvisible Inc develops patented polymer delivery system Invisicare for enhanced skin care product delivery.
  • Invisicare extends the duration of active ingredients on skin without alcohol or solvents.
  • Skinvisible has formulated over forty topical skin products using Invisicare technology.

Weaknesses

  • Skinvisible Inc employs only two full-time employees in Las Vegas, Nevada.
  • The company has been listed since 7 January 1999 with limited growth.
  • Skinvisible's business is solely focused on a single patented technology.

Opportunities

  • Skinvisible can expand Invisicare technology into new skin care product segments.
  • The growing global skin care market offers opportunities for Invisicare adoption.
  • Skinvisible may partner with larger firms to scale Invisicare production.

Threats

  • Skinvisible faces competition from established skin care brands with larger R&D budgets.
  • Patent expiration could threaten Invisicare's exclusive technology advantage.
  • Economic downturns may reduce consumer spending on skin care products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.